Azenta (NASDAQ:AZTA) Stock Price Target Raised at Needham & Company LLC

Azenta (NASDAQ:AZTA) had its target price boosted by Needham & Company LLC from $37.00 to $57.00 in a research report report published on Wednesday morning,Benzinga reports. They currently have a buy rating on the stock.

Several other research analysts also recently commented on the company. Weiss Ratings raised Azenta from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, August 26th. Jefferies Financial Group raised their price objective on shares of Azenta from $44.00 to $52.00 and gave the stock a “buy” rating in a research note on Wednesday. Finally, Wall Street Zen lowered shares of Azenta from a “buy” rating to a “hold” rating in a research report on Sunday, October 18th. Four research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Azenta presently has an average rating of “Hold” and a consensus target price of $47.60.

Azenta Stock Performance

Shares of NASDAQ:AZTA opened at $48.90 on Wednesday. The stock’s 50-day moving average is $35.98 and its 200-day moving average is $28.51. The company has a market cap of $2.14 billion, a P/E ratio of -13.51 and a beta of 1.47. Azenta has a 52-week low of $15.93 and a 52-week high of $50.06.

Azenta (NASDAQ:AZTA) last posted its quarterly earnings data on Tuesday, November 10th. The company reported $0.28 earnings per share for the quarter, topping the consensus estimate of $0.11 by $0.17. Azenta had a positive return on equity of 1.37% and a negative net margin of 26.86%. The business had revenue of $167.09 million during the quarter, compared to analysts’ expectations of $160.16 million.

Institutional Trading of Azenta

Large investors have recently bought and sold shares of the stock. BlackRock Inc. bought a new position in shares of Azenta in the second quarter valued at approximately $192,152,000. Allspring Global Investments Holdings LLC lifted its position in Azenta by 16.3% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 1,613,914 shares of the company’s stock worth $34,183,000 after buying an additional 225,867 shares in the last quarter. Front Street Capital Management Inc. acquired a new stake in Azenta in the 2nd quarter valued at about $33,212,000. American Capital Management Inc. raised its stake in shares of Azenta by 26.9% in the first quarter. American Capital Management Inc. now owns 1,296,024 shares of the company’s stock worth $27,385,000 after acquiring an additional 274,588 shares during the last quarter. Finally, GW&K Investment Management LLC lifted its position in shares of Azenta by 0.4% during the third quarter. GW&K Investment Management LLC now owns 992,616 shares of the company’s stock worth $34,633,000 after purchasing an additional 4,187 shares in the last quarter. 99.08% of the stock is currently owned by institutional investors.

Latest Azenta News

Here’s some of the latest news about AZTA:

• Positive Sentiment: Better FY2027 outlook: The company forecast revenue of $648 million to $660 million, above the $632.4 million consensus, with organic growth of 3%–5% after 2% in FY2026. It also expects adjusted EBITDA margin to expand by roughly 200–250 basis points, signaling improving business momentum. Azenta FY2026 results and FY2027 outlook
• Positive Sentiment: Buyback support: Azenta repurchased 4.4 million shares for $118.2 million in FY2026 and ended the year with $506 million in cash and marketable securities, providing financial flexibility and supporting per-share value. Azenta share repurchases and outlook
• Negative Sentiment: Legal overhang: Rosen Law Firm announced an investigation into possible securities claims alleging Azenta may have provided materially misleading business information. The claims are allegations, not findings, but could add uncertainty for investors. Securities class action investigation announcement

About Azenta

Azenta, Inc. provides products and services for life sciences research and the management of biological samples. Its offerings include automated sample storage systems, laboratory automation equipment, consumables, and software used to track and manage samples. The company also provides genomic services through GENEWIZ, including sequencing and other genetic analysis services for researchers and organizations in the life sciences and pharmaceutical industries. Azenta was formed in 2021 when Brooks Automation separated its life sciences business and adopted the Azenta name.